AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2019
Jan 10, 2019
34931_dirs_2019-01-10_ea624408-b1fe-4d55-bf9b-766080559fb3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2019-01-08
Reporting Person: MYERS STEVEN S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-08 | Common Stock | A | 8747 | — | Acquired | 44906 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8434 | Indirect |
| Common Stock | 802 | Indirect |
| Common Stock | 1954 | Indirect |
Footnotes
F1: Represents 8,747 shares underlying restricted stock granted under the 2018 Equity Incentive Compensation Plan which were awarded on January 8, 2018 and which vested on January 8, 2019.